XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Revenues $ 195 $ 231 $ 390 $ 385
Cost of revenues (6) (7) (12) (12)
Gross profit 189 224 378 373
Research and development expenses (4,146) (2,969) (7,894) (5,832)
Less participation by the Office of the Chief Scientist and other parties 493 1,902 1,543 1,921
Research and development expenses, net (3,653) (1,067) (6,351) (3,911)
General and administrative expenses (1,420) (1,275) (3,101) (2,912)
Operating loss (4,884) (2,118) (9,074) (6,450)
Financial income (expenses), net 394 126 589 (35)
Net loss for the period $ (4,490) $ (1,992) $ (8,485) $ (6,485)
Loss per share:        
Basic and diluted net loss per share $ (0.08) $ (0.05) $ (0.16) $ (0.15)
Weighted average number of shares used in computing basic and diluted net loss per share 57,512,930 43,669,466 52,659,430 43,225,017